Literature DB >> 34914605

Abernethy malformation: A comprehensive review.

Parveen Kumar1, Mona Bhatia1, Amit Garg1, Shashank Jain1, Khemendra Kumar1.   

Abstract

Abernethy malformation is a rare condition in which portomesenteric blood bypasses the liver and drains into the systemic vein through a partial or complete shunt. It is categorised into two types on the basis of the shunt pattern between the portal vein and systemic vein. Abernethy malformation is associated with multiple congenital anomalies and acquired complications. A detailed understanding of anatomy and embryology is a prerequisite to interpret the imaging findings. Computed tomography and magnetic resonance angiography can delineate the shunt anatomy and evaluate the concomitant malformations. It is essential to differentiate Abernethy malformation from intrahepatic portosystemic shunts and acquired extrahepatic portosystemic shunts. Mild metabolic abnormalities are treated with dietary modifications and medical therapy. Definitive treatment is done in symptomatic patients. Generally, type I Abernethy patients undergo liver transplantation, and type II undergo shunt occlusion by surgery or transcatheter coiling.

Entities:  

Mesh:

Year:  2022        PMID: 34914605     DOI: 10.5152/dir.2021.20474

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN: 1305-3825            Impact factor:   2.630


  3 in total

1.  Type II Abernethy Malformation: A Rare Cause of Hepatic Encephalopathy in Adulthood.

Authors:  Inês Gonçalves; Daniela Barros; Margarida Araújo; Ana Isabel Machado; Camila Oliveira; Luisa Pinto
Journal:  Eur J Case Rep Intern Med       Date:  2022-01-26

2.  A rare presentation of type II Abernethy malformation and nephrotic syndrome: Case report and review.

Authors:  Xin Wu; Weizhong Gu; Yongzhi Lin; Lina Ye
Journal:  Open Life Sci       Date:  2022-07-21       Impact factor: 1.311

3.  Case report: Rare abernethy malformation with hepatopulmonary syndrome in a pediatric patient.

Authors:  Lianfu Ji; Zhaoming Ji; Dandan Xiang; Yuming Qin; Shiwei Yang
Journal:  Front Pediatr       Date:  2022-09-09       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.